An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

NCT00696995 · clinicaltrials.gov ↗

COMPLETED

Status

509

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 30

Sponsor

Novo Nordisk A/S